BLADDER CANCER RECURRENT

Clinical trials for BLADDER CANCER RECURRENT explained in plain language.

Never miss a new study

Get alerted when new BLADDER CANCER RECURRENT trials appear

Sign up with your email to follow new studies for BLADDER CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New bladder cancer drug aims to match gold standard in major trial

Disease control Recruiting now

This Phase 3 trial tests a new treatment called VERITY-BCG for people with intermediate or high-risk non-muscle invasive bladder cancer who have not received BCG therapy before. The study compares VERITY-BCG to the standard BCG treatment (OncoTICE) to see if it works just as well…

Matched conditions: BLADDER CANCER RECURRENT

Phase: PHASE3 • Sponsor: Verity Pharmaceuticals Inc. • Aim: Disease control

Last updated May 15, 2026 11:54 UTC

BLADDER CANCER RECURRENT

Get alerted when new BLADDER CANCER RECURRENT trials appear

New bladder cancer drug aims to match gold standard in major trial